标题
Gut microbiome in primary sclerosing cholangitis: A review
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 21, Pages 2768-2780
出版商
Baishideng Publishing Group Inc.
发表日期
2020-06-05
DOI
10.3748/wjg.v26.i21.2768
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways
- (2020) Mohammed Nabil Quraishi et al. Journal of Crohns & Colitis
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
- (2019) Nobuhiro Nakamoto et al. Nature Microbiology
- Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
- (2019) Brian M Fung et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis
- (2019) Jessica R. Allegretti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
- (2019) Sara Lemoinne et al. GUT
- The gut microbial influence on cholestatic liver disease
- (2019) Martin Kummen et al. LIVER INTERNATIONAL
- Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
- (2019) Malte Rühlemann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2019) Ayesha Shah et al. SEMINARS IN LIVER DISEASE
- Pharmacologic management of primary sclerosing cholangitis: what’s in the pipeline?
- (2019) Jaspreet Suri et al. Expert Review of Gastroenterology & Hepatology
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
- (2019) Sara Vieira-Silva et al. Nature Microbiology
- Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease
- (2019) M. N. Quraishi et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption
- (2019) Yong-Dong Deng et al. Gut Pathogens
- Diversification of host bile acids by members of the gut microbiota
- (2019) Jenessa A. Winston et al. Gut Microbes
- Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
- (2018) M. E. Joosse et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon
- (2018) Noa Krugliak Cleveland et al. Clinical Gastroenterology and Hepatology
- Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
- (2018) Amanda Ricciuto et al. Clinical Gastroenterology and Hepatology
- PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
- (2018) N.F. Larusso et al. DIGESTIVE AND LIVER DISEASE
- Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor–Positive Cells and Pathogenesis of Cholestatic Liver Disease
- (2018) Dana Tedesco et al. GASTROENTEROLOGY
- Colesevelam attenuates cholestatic liver and bile duct injury inMdr2−/−mice by modulating composition, signalling and excretion of faecal bile acids
- (2018) Claudia Daniela Fuchs et al. GUT
- Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features
- (2018) Carolina Palmela et al. Gut and Liver
- Primary sclerosing cholangitis
- (2018) Jessica K Dyson et al. LANCET
- Urbanization and the gut microbiota in health and inflammatory bowel disease
- (2018) Tao Zuo et al. Nature Reviews Gastroenterology & Hepatology
- Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration
- (2018) Umang Jain et al. Cell Host & Microbe
- Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
- (2018) Amandeep K Dhillon et al. LIVER INTERNATIONAL
- Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells
- (2018) Franziska Mathies et al. JOURNAL OF IMMUNOLOGY
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
- (2017) Tobias J. Weismüller et al. GASTROENTEROLOGY
- Fungal dysbiosis in cirrhosis
- (2017) Jasmohan S Bajaj et al. GUT
- The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
- (2017) Mark R. Deneau et al. HEPATOLOGY
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
- (2017) David N. Assis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Genetics of primary sclerosing cholangitis and pathophysiological implications
- (2017) Xiaojun Jiang et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiota and IBD: causation or correlation?
- (2017) Josephine Ni et al. Nature Reviews Gastroenterology & Hepatology
- Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
- (2017) Lukas Bajer et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
- (2017) J Torres et al. United European Gastroenterology Journal
- The features of mucosa-associated microbiota in primary sclerosing cholangitis
- (2016) J. Torres et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
- (2016) Long-Xian Lv et al. ENVIRONMENTAL MICROBIOLOGY
- Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
- (2016) Aida Kapic Lunder et al. GASTROENTEROLOGY
- Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
- (2016) Malte Christoph Rühlemann et al. GUT
- The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
- (2016) Mohammed Nabil Quraishi et al. GUT
- Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis
- (2016) Kentaro Iwasawa et al. GUT
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
- (2016) João Sabino et al. GUT
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- (2015) James H. Tabibian et al. HEPATOLOGY
- Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
- (2015) D. Kevans et al. Journal of Crohns & Colitis
- Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study
- (2015) Peter De Cruz et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
- (2014) Phillip L. Molyneaux et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
- (2014) Noortje G. Rossen et al. Journal of Crohns & Colitis
- G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
- (2014) Klemens Högenauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Mortality in inflammatory bowel disease patients under 65 years of age
- (2014) Aoibhlinn O'Toole et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history
- (2013) Mark Deneau et al. HEPATOLOGY
- Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
- (2013) Janosch Katt et al. HEPATOLOGY
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Isolation and characterization of a bile acid inducible 7α-dehydroxylating operon in Clostridium hylemonae TN271
- (2009) Jason M. Ridlon et al. ANAEROBE
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome
- (2008) B. V. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now